Treace Medical Concepts Inc - Asset Resilience Ratio
Treace Medical Concepts Inc (TMCI) has an Asset Resilience Ratio of 22.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Treace Medical Concepts Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Treace Medical Concepts Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see TMCI current and non-current assets.
Liquid Assets Composition Over Time
This chart breaks down Treace Medical Concepts Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read TMCI current and long-term liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $42.31 Million | 22.98% |
| Total Liquid Assets | $42.31 Million | 22.98% |
Asset Resilience Insights
- Good Liquidity Position: Treace Medical Concepts Inc maintains a healthy 22.98% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Treace Medical Concepts Inc Industry Peers by Asset Resilience Ratio
Compare Treace Medical Concepts Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for Treace Medical Concepts Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Treace Medical Concepts Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.76% | $37.66 Million | $190.58 Million | -9.87pp |
| 2024-12-31 | 29.63% | $64.33 Million | $217.09 Million | -14.12pp |
| 2023-12-31 | 43.75% | $110.22 Million | $251.91 Million | +4.90pp |
| 2022-12-31 | 38.85% | $61.78 Million | $159.02 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $140.82 Million | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more